Compare Pfizer Inc (PFE) vs Western Digital Corp (WDC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Pfizer Inc vs Western Digital Corp — how do they compare? Pfizer Inc trades at $27.78 (market cap $159.59B), while Western Digital Corp trades at $399.59 (market cap $151.76B). The key difference: Pfizer Inc and Western Digital Corp are close in size by market cap, and Pfizer Inc pays the higher dividend (6.14%). Which is the better fit depends on your goals — on Pluang, investors hold Pfizer Inc for 158 Days and Western Digital Corp for 37 Days on average.
| PFE | WDC | |
|---|---|---|
Market Cap | $159.59B | $151.76B |
Volume | 30,937,010 | 7,162,789 |
Sector | Health | Technology |
52-Week High | $29.02 | $746.23 |
52-Week Low | $23.67 | $113.13 |
Typical Hold Time | 158 Days | 37 Days |
Enterprise Value | $211.09B | $151.23B |
Dividend Yield | 6.14% | 0.15% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Pfizer (PFE) trades at $27.82, up 1.22% with a bullish technical signal from moving averages. The company shows stable revenue around $62-63B with consistent earnings beats in recent quarters. Analysts maintain a $29.40 consensus target with 40% buy ratings. Recent news highlights Pfizer's focus on obesity and oncology pipelines as key growth drivers.
Pfizer offers value with defensive cash flows and dividend stability, though patent cliffs and margin compression present challenges. The stock's current valuation appears reasonable relative to sector peers, with upside potential if pipeline developments succeed. Key risks include competitive pressures and regulatory hurdles for new drug approvals.
Western Digital (WDC) trades at $393.31, down 4.31% amid concerns about increased competition from Toshiba's planned HDD production expansion. The stock shows strong fundamentals with a P/E of 15.06 and impressive profitability metrics including 131.02% ROE and 71.97% net income margin. Recent earnings have consistently beaten expectations, with Q2 2026 EPS of $3.56 exceeding the $3.31 estimate. Technical indicators show bearish momentum with the price testing key support levels around $391-$400.
Despite near-term competitive pressures, Western Digital maintains strong analyst support with 72% buy ratings and a $647.58 consensus price target representing 65% upside. The company's dominant 40%+ market share in HDDs and AI-driven storage demand provide long-term growth catalysts, though investors should monitor Toshiba's capacity expansion impact on pricing power and margins in the competitive storage market.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Pfizer Inc
Pfizer Inc. operates as a pharmaceutical company. The Company offers medicines, vaccines, medical devices, and consumer healthcare products for oncology, inflammation, cardiovascular, and other therapeutic areas. Pfizer serves customers worldwide.
Read more on PFE →About Western Digital Corp
Western Digital is a vertically integrated supplier of data storage solutions, spanning both hard disk drives and solid-state drives. In the HDD market it forms a practical duopoly with Seagate, and it is the largest global producer of NAND flash chips for SSDs in a joint venture with competitor Kioxia.
Read more on WDC →
